Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths…
Weakened US fuel-efficiency rules and promises of cheaper cars could yet see drivers pay higher running costs while increasing planet-heating emissions.